Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results (Q36947391)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 2008

Language	Label	Description	Also known as
English	Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results	scientific article published on November 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

0 references

0 references

hyperparathyroidism

1 reference

based on heuristic

inferred from title

secondary hyperparathyroidism

1 reference

based on heuristic

inferred from title

Steven L. Vicks

4

object named as

Steven L Vicks

0 references

author name string

Steven Fishbane

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Warren B Shapiro

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dalila B Corry

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Michael Roppolo

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Kenneth Rappaport

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Xiang Ling

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

William G Goodman

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stewart Turner

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Chaim Charytan

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Clinical Journal of the American Society of Nephrology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1718-1725

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Parathyroid hormone: new assays, new receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

29 September 2017

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

27 June 2018

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

27 June 2018

Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

27 June 2018

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

27 June 2018

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

4 September 2018

Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

20 October 2018

Calcitriol pulse therapy for severe hyperparathyroidism or calcium salts as phosphate binders in renal dialysis patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572296

20 October 2018

Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2215/CJN.01040308

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36947391&oldid=1664394264"